YONDELIS (Trabectedin)-1mg

YONDELIS® (Trabectedin) works by sticking to the DNA in cells and damaging it. This stops the cancer cells growing and multiplying.

Indicated for the treatment of patients with unresectable or metastatic liposarcoma or leiomyosarcoma who received a prior anthracycline-containing regimen. It is also used in treatment for advanced soft tissue sarcoma & ovarian cancer that has come back.

Enquiry Now
Category:

Additional information

Trade Name

YONDELIS

Generic Name

Trabectedin

Manufacturer

Pharma Mar /Janssen

Drug Type

oncology

Indication

Ovarian cancer

Doasage Form

Injectible

Packaging

1 x 1mg